Vista Pharmaceuticals share news, announcements and annual reports
BSE: 524711Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹6.45.
30 Oct: open ₹6.50, high ₹6.50, low ₹6.15
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹38 Cr3,508th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.05
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −28.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −32.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.27
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,884
Vista Pharmaceuticals share news and announcements
532 announcements, routine notices left out, newest first. Page 5 of 11.
Mar 2021
Feb 2021
2 Feb · Board meeting
Meeting on 12 Feb 2021: quarterly results
Jan 2021
13 Jan · Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 011 Jan · Shareholding for the Period Ended December 31, 2020
Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click ....
Dec 2020
30 Dec · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....10 Dec · Legal
Exchange has sought clarification from Vista Pharmaceuticals Ltd on December 10, 2020, with reference to Movement in Price. The reply is awaited.
Nov 2020
5 Nov · Board meeting
Meeting on 12 Nov 2020: quarterly results
Oct 2020
23 Oct · Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015-For The Half Year Ended 30.09.2020.
23 Oct · Certificate In Terms Of Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
16 Oct · Shareholding for the Period Ended September 30, 2020
Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click ....14 Oct · Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2020
7 Sep · Board meeting
Meeting on 14 Sep 2020: quarterly results
Aug 2020
13 Aug · Shareholding for the Period Ended August 03, 2020
Shareholding Pattern for the Period Ended August 03, 2020. For more details, kindly Click ....3 Aug · Announcement under Regulation 30 (LODR)-Allotment
Jul 2020
21 Jul · Shareholding for the Period Ended July 13, 2020
Shareholding Pattern for the Period Ended July 13, 2020. For more details, kindly Click ....21 Jul · Shareholding for the Period Ended July 07, 2020
Shareholding Pattern for the Period Ended July 07, 2020. For more details, kindly Click ....14 Jul · Shareholding for the Period Ended June 30, 2020
Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click ....14 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 013 Jul · Announcement under Regulation 30 (LODR)-Allotment
13 Jul · Board meeting
Meeting on 20 Jul 2020: audited results and quarterly results7 Jul · Announcement under Regulation 30 (LODR)-Allotment
Jun 2020
29 Jun · Results
Details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....